Enforcement
Administrative Fine Imposed on the Responsible Person of The PharmaCore Biotech Co., Ltd. (Listed Company 6713)
2021-08-12
1. Date the fine was imposed: August 12, 2021
2. Recipient of the fine: PharmaCore Biotech Co., Ltd.
3. Legal basis of the fine: Paragraph 1(3) of Article 36 of the Securities and Exchange Act.
4. Facts of the violation and reasons: The PharmaCore Biotech Co., Ltd. failed to complete the regulatory filing of the overview of operations in June 2021 by July 10, 2021 and, therefore, should be held violating Paragraph 1(3) of Article 36 of the Securities and Exchange Act.
5. Resulting fine: Sentenced to the fine, NT$240,000, in accordance with Paragraph 1(4) of Article 178 and Article 179 of the Securities and Exchange Act.
2. Recipient of the fine: PharmaCore Biotech Co., Ltd.
3. Legal basis of the fine: Paragraph 1(3) of Article 36 of the Securities and Exchange Act.
4. Facts of the violation and reasons: The PharmaCore Biotech Co., Ltd. failed to complete the regulatory filing of the overview of operations in June 2021 by July 10, 2021 and, therefore, should be held violating Paragraph 1(3) of Article 36 of the Securities and Exchange Act.
5. Resulting fine: Sentenced to the fine, NT$240,000, in accordance with Paragraph 1(4) of Article 178 and Article 179 of the Securities and Exchange Act.
- Visitor： 10090
- Update： 2021-08-16
